DD vs NAGE · P/E 127, rev $12.39B vs P/E 59, rev $99.6M
Dupont De Nemours Inc (DD) versus Niagen Bioscience, Inc. (NAGE) — a side-by-side from cached financials, not a winner call.
Dupont De Nemours Inc (DD) is a specialty chemicals company listed on US.
Niagen Bioscience, Inc. (NAGE) is a biotechnology company listed on US.
Latest reported DD revenue for 2024-12-31 was $12.39B. Net income was $738.0M. Revenue was up 2.6% from 2023-12-31 to 2024-12-31. DD currently screens at market cap $19.61B and trailing P/E 127.4.
Latest reported NAGE revenue for 2024-12-31 was $99.6M. Net income was $8.6M. Revenue was up 19.2% from 2023-12-31 to 2024-12-31. NAGE currently screens at market cap $836.5M and trailing P/E 59.0.
DD currently screens at market cap $19.61B and trailing P/E 127.4. NAGE currently screens at market cap $836.5M and trailing P/E 59.0.
Not investment advice. Open the DD and NAGE stock pages for the full models.
Not investment advice.